Skip to main content

Inspection visit

Health inspection

ALMOND VIEW CARE CENTERCMS #5552002 citations on this visit
2 citations recorded

Inspector’s narrative

What the inspector wrote

This survey cited 2 deficiencies. The full statement and the facility’s plan of correction follow, verbatim from the federal record.

F 0644 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few Coordinate assessments with the pre-admission screening and resident review program; and referring for services as needed. Based on interviews, record reviews, and facility policy review, the facility failed to refer 2 (Resident #40 and Resident #55) of 4 sampled residents reviewed for preadmission screening and resident review (PASARR) when the resident received a new mental illness diagnosis. Findings included: Review of the facility policy titled, Resident Assessment-Coordination with PASARR Program, implemented on 07/23/2023, revealed, This facility coordinates assessments with the preadmission screening and resident review program under Medicaid to ensure that individuals with a mental disorder [MD], intellectual disability [ID], or a related condition receives care and services in the most integrated setting appropriate to their needs. The policy specified, The facility must screen the individual using the State's Level I screening process and refer any resident who has or may have MD, ID or a related condition to the appropriate state-designated authority for Level II PASARR evaluation and determination. Review of Resident #40's admission Record revealed the facility admitted the resident on 02/02/2022. Per the admission Record, on 02/17/2022, the resident received a diagnosis of post-traumatic stress disorder, on 03/18/2022, a diagnosis of anxiety disorder, and on 09/26/2023, a diagnosis of depression. Review of Resident #40's quarterly Minimum Data Set (MDS), with an Assessment Reference Date (ARD) of 05/11/2022, revealed the resident had a Brief Interview for Mental Status (BIMS) score of 10, which indicated the resident had moderate cognitive impairment. The MDS revealed the resident had active diagnoses to include anxiety disorder and post-traumatic stress disorder. Review of Resident #55's admission Record revealed the facility admitted the resident on 06/24/2019. Pe the admission Record, the resident received a diagnosis of generalized anxiety disorder on 04/07/2022. Review of Resident #55's quarterly MDS, with an ARD of 06/17/2022, revealed Resident #55 had a BIMS score of 6, which indicated the resident had severe cognitive impairment. The MDS revealed the resident had active diagnoses to include anxiety disorder, depression, and psychotic disorder. During an interview on 01/23/2024 at 9:50 AM, the MDS Director, stated a new PASARR screen was not completed for Resident #40 or Resident #55 when the residents received new mental health diagnoses. The MDS Director stated she thought a new PASSAR was only required if the resident had behaviors or symptoms after receiving a new mental health diagnosis. (continued on next page) Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 3 Event ID: 555200 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 555200 B. Wing A. Building (X3) DATE SURVEY COMPLETED 01/23/2024 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Almond View Care Center 1224 E Street Williams, CA 95987 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0644 Level of Harm - Minimal harm or potential for actual harm During an interview on 01/23/2024 at 10:59 AM, the Administrator stated she did not think that a new mental illness diagnosis would require a new PASSAR to be completed. During an interview on 01/23/2024 at 11:17 AM, the Director of Nursing stated she did not do PASSARs, but she expected the policy to be followed. Residents Affected - Few FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 555200 If continuation sheet Page 2 of 3 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 555200 B. Wing A. Building (X3) DATE SURVEY COMPLETED 01/23/2024 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Almond View Care Center 1224 E Street Williams, CA 95987 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0645 PASARR screening for Mental disorders or Intellectual Disabilities Level of Harm - Minimal harm or potential for actual harm Based on interviews, record review, and facility policy review, the facility failed to ensure the accuracy of the preadmission screening and resident review (PASARR) level I screening for 1 (Resident #77) of 4 sampled residents reviewed for PASARR. Residents Affected - Few Findings included: Review of the facility policy titled, Resident Assessment-Coordination with PASARR Program, implemented on 07/23/2023, revealed, This facility coordinates assessments with the preadmission screening and resident review program under Medicaid to ensure that individuals with a mental disorder, intellectual disability, or a related condition receives care and services in the most integrated setting appropriate to their needs. Policy Explanation and Compliance Guidelines: 1. All applicants to this facility will be screened for serious mental disorders or intellectual disabilities and related conditions in accordance with the State's Medicaid rules for screening. A review of Resident #77's admission Record revealed the facility admitted the resident on 12/09/2023, with diagnoses that included bipolar disorder, major depressive disorder, and anxiety disorder. A review of Resident #77's Preadmission Screening and Resident Review Level I Screening, dated12/08/2023, revealed the resident did not have a serious diagnosed mental disorder such as depression disorder, anxiety disorder, panic disorder, schizophrenia/schizoaffective disorder, or symptoms of psychosis, delusions, ad/or mood disturbance. A review of Resident #77's admission Minimum Data Set (MDS), with an Assessment Reference Date (ARD) of 12/13/2023, revealed the resident had a Brief Interview for Mental Status (BIMS) score of 4, which indicated the resident had severe cognitive impairment. The MDS revealed the resident had active diagnoses to include anxiety disorder, depression, and bipolar disorder. A review of Resident #77's Order Summary Report, with active orders as of 01/23/2024, revealed an order dated 12/30/2023, for olanzapine (an antipsychotic medication) oral tablet 10 milligram (mg), give one tablet by mouth at bedtime for bipolar disorder and nortriptyline oral capsule 25 mg, give one capsule by mouth at bedtime for depression. During an interview on 01/23/2024 at 9:50 AM, the MDS Director indicated she was responsible for completing the PASARRs. When she would get the initial packet from the hospital, she would look through it and see if there were any mental diagnoses for the resident and add them to the Level I. Sometimes The MDS Director confirmed Resident #77's PASARR level I screening was inaccurate. Per the MDS Director, a level II examination should have been done for Resident #77. During an interview on 01/23/2024 at 11:00 AM, the Administrator stated Resident #77's mental illness diagnoses should have been included on the resident's PASARR level I screening. During an interview on 01/23/2024 at 11:17 AM, the Director of Nursing (DON) stated she did not do anything specific with the PASARRs, but indicated the PASARR was important to see what other services may be available for the resident. The DON stated her expectation was during the admission process, staff would make sure the documentation was correct. FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 555200 If continuation sheet Page 3 of 3

Reading this as a family member? Your long-term care ombudsman is a free advocate for residents and families.

Back to top

Citations

2 citations recorded*CMS

What do CMS severity letters mean?

Serious (G-L). Actual harm to a resident, or immediate jeopardy. Codes G through I indicate actual harm; J through L indicate immediate jeopardy to resident health or safety.

General (A-F). No actual harm found, or harm that is minimal. The facility must still submit a Plan of Correction. Most CMS citations land here.

Each letter combines severity with scope: how many residents the deficiency affected.

  • 0644GeneralS&S Dpotential for harm

    F644 - Coordination

    Coordinate assessments with the pre-admission screening and resident review program; and referring for services as needed.

  • 0645GeneralS&S Dpotential for harm

    F645 - Preadmission Screening for individuals with a mental disorder and individuals

    PASARR screening for Mental disorders or Intellectual Disabilities

FAQ · About this visit

Common questions about this visit

What happened during the January 23, 2024 survey of ALMOND VIEW CARE CENTER?

This was a inspection survey of ALMOND VIEW CARE CENTER on January 23, 2024. The surveyor cited 2 deficiencies, recorded on the federal Form 2567 statement of deficiencies.

Were any deficiencies cited at ALMOND VIEW CARE CENTER on January 23, 2024?

Yes, 2 deficiencies were cited, each with a CMS Scope and Severity grade. The first was: "Coordinate assessments with the pre-admission screening and resident review program; and referring for services as neede..."

What type of survey was this?

This was a inspection survey conducted by state surveyors under federal Centers for Medicare & Medicaid Services (CMS) oversight. Findings are published on CMS Care Compare.

Share this reportEmail

Next steps

Concerned about a resident’s care?Find your local ombudsman through the Eldercare Locatoror file a complaint with your state survey agency.

Researching this visit professionally?Book a 15-minute calland we will walk through what we have on file.

Data from CMS Care Compare public records. Dataset last refreshed . If you believe any information is inaccurate, report it here.